Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid β scavenger protein

Journal of Alzheimer's Disease

Volumn 6, Issue 4, 2004, Pages 413-420

  Tang, Yu Ping ^a   Haslam, Sandra Z ^a   Conrad, Susan E ^a   Sisk, Cheryl L ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Estrogen; Transthyretin

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; PREALBUMIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CHOROID PLEXUS; CONTROLLED STUDY; DNA MICROARRAY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; LEPTOMENINX; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; RIBONUCLEASE PROTECTION ASSAY; RISK FACTOR; SENILE PLAQUE;

EID: 4644223293     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6409     Document Type: Article

References (33)

1. S. Gandy and K. Duf, Post-menopausal estrogen deprivation and Alzheimer's disease, Exp Gerontol 35(4) (2000), 503-511.
2. V.W. Henderson, The epidemiology of estrogen replacement therapy and Alzheimer's disease, Neurology 48(5 Suppl 7) (1997), 27-35.
3. R.A. Lobo, Benefits and risks of estrogen replacement therapy, Am J Obstet Gynecol 173(3 Pt 2) (1995), 982-989.
4. M.X. Tang, D. Jacobs and Y. Stern et al., Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease, Lancet 348(9025) (1996), 429-432.
5. P.P. Zandi, M.C. Carlson, B.L. Plassman et al., Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study, JAMA 288(17) (2002), 2123-2129.
6. R.D. Brinton, Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges, Learn Mem 8(3) (2001), 121-133.
7. B.B. Sherwin, Estrogen and cognitive functioning in women, Endocr Rev 24(2) (2003), 133-151.
8. S.R. Rapp, M.A. Espeland, S.A. Shumaker et al., Effect of estrogen plus progestin on global cognitive function in post-menopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, JAMA 289(20) (2003), 2663-2672.
9. S.A. Shumaker, C. Legault, S.R. Rapp et al., Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, JAMA 289(20) (2003), 2651-2662.
10. S.S. Petanceska, V. Nagy, D. Frail and S. Gandy, Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, Exp Gerontol 35(9-10) (2000), 1317-1325.
11. H. Zheng, H. Xu, S.N. Uljon et al., Modulation of A(beta) peptides by estrogen in mouse models, J Neurochem 80(1) (2002), 191-196.
12. J.A. Levin-Allerhand and J.D. Smith, Ovariectomy of young mutant amyloid precursor protein transgenic mice leads to increased mortality, J Mol Neurosci 19(1-2) (2002), 163-166.
13. J.P. Chanoine, S. Alex, S.L. Fang et al., Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain, Endocrinology 130(2) (1992), 933-938.
14. G. Schreiber, A.R. Aldred, A. Jaworowski, C. Nilsson, M.G. Achen and M.B. Segal, Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus, Am J Physiol 258(2 Pt 2) (1990), 338-345.
15. G. Schreiber and S.J. Richardson, The evolution of gene expression, structure and function of transthyretin, Comp Biochem Physiol B Biochem Mol Biol 116(2) (1997), 137-160.
16. H.L. Monaco, The transthyretin-retinol-binding protein complex, Biochim Biophys Acta 1482(1-2) (2000), 65-72.
17. H.L. Monaco, Three-dimensional structure of the transthyretin-retinol- binding protein complex, Clin Chem Lab Med 40(12) (2002), 1229-1236.
18. A.L. Schwarzman, L. Gregori, M.P. Vitek et al., Transthyretin sequesters amyloid beta protein and prevents amyloid formation, Proc Natl Acad Sci USA 91(18) (1994), 8368-8372.
19. E. Carro, J.L. Trejo, T. Gomez-Isla, D. LeRoith and I. Torres Aleman, Serum insulin-like growth factor 1 regulates brain amyloid-beta levels, Nat Med 8(12) (2002), 1390-1397.
20. J.M. Serot, D. Christmann, T. Dubost and M. Couturier, Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease, J Neurol Neurosurg Psychiatry 63(4) (1997), 506-508.
21. A.M. Raafat, L.J. Hofseth, S. Li, J.M. Bennett and S.Z. Haslam, A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice, Endocrinology 140(6) (1999), 2570-2580.
22. A.M. Raafat, S. Li, J.M. Bennett, L.J. Hofseth and S.Z. Haslam, Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a post-menopausal mouse model, J Cell Physiol 187(1) (2001), 81-89.
23. A.M. Raafat, L.J. Hofseth and S.Z. Haslam, Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model, Am J Obstet Gynecol 184(3) (2001), 340-349.
24. J.M. Meredith, C.J. Auger and J.D. Blaustein, Downregulation of estrogen receptor immunoreactivity by 17 beta-estradiol in the guinea pig forebrain, J Neuroendocrinol 6(6) (1994), 639-648.
25. A. Merched, J.M. Serot, S. Visvikis, D. Aguillon, G. Faure and G. Siest, Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry, FEBS Lett 425(2) (1998), 225-228.
26. U. Samadani, X. Qian and R.H. Costa, Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3 beta isoform, Gene Expr 6(1) (1996), 23-33.
27. P.J. Kushner, D.A. Agard, G.L. Greene et al., Estrogen receptor pathways to AP-1, J Steroid Biochem Mol Biol 74(5) (2000), 311-317.
28. M.M. Miller, A.A. Monjan and N.S. Buckholtz, Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease, Ann N Y Acad Sci 949 (2001), 223-234.
29. R.A. Mulnard, C.W. Cotman, C. Kawas et al., Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study, JAMA 283(8) (2000), 1007-1015.
30. R.L. Bowen, G. Verdile, T. Liu et al., Luteinizing Hormone, a Reproductive Regulator that Modulates the Processing of Amyloid-beta Precursor Protein and Amyloid-beta Deposition, J Biol Chem (2004).
31. P. Seubert, C. Vigo-Pelfrey, F. Esch et al., Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids, Nature 359(6393) (1992), 325-327.
32. M. Shoji, T.E. Golde, J. Ghiso et al., Production of the Alzheimer amyloid beta protein by normal proteolytic processing, Science 258(5079) (1992), 126-129.
33. T.D. Stein and J.A. Johnson, Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways, J Neurosci 22(17) (2002), 7380-7388.